FOG PHARMACEUTICALS, INC. — Form D/A
FOG PHARMACEUTICALS, INC. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-05-16. The offering totals $66.0M, of which $65.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-05-16
- Form: D/A
- Accession: 0001657677-18-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $66.0M
- Amount sold: $65.5M
- Remaining: $500K
- Investors: 24
- Date of first sale: 2018-02-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-305650
Issuer
- Name: FOG PHARMACEUTICALS, INC.
- CIK: 0001657677
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 30 ACORN PARK DRIVE, CAMBRIDGE, MA, 02140
- Phone: 617-945-9510
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Leon A Chen | Director | Cambridge, MA |
| Edward A Fitzgerald | Director | Cambridge, MA |
| Leon M Chen | Director | Hayward, CA |
| WeiQing M Zhou | Executive Officer | Cambridge, MA |
| Krishna M Yeshwant | Director | Cambridge, MA |
| Rick M Klausner | Director | Cambridge, MA |
| Barbara M Weber | Director | Cambridge, MA |
| Jeffrey A Leerink | Director | Cambridger, MA |
| Edward M Fitzgerald | Director | Camnbridger, MA |
| WeiQing A Zhou | Executive Officer | Boston, MA |
| Gregory L Verdine | Director | Cambridge, MA |
| Gregory L Verdine | Executive Officer | Cambridge, MA |
| Michael L Aceti | Executive Officer | Boston, MA |
| WeiQing L Zhou | Executive Officer | Boston, MA |
| Corey S Goodman | Director | Austin, TX |
Other filings by this issuer (6)
More